Danirixin

Catalog No. :
ACFKWI421
CAS No. :
954126-98-8
Molecular Formula :
C19H21ClFN3O4S
Molecular Weight :
441.91

IUPAC Name:(S)-1-(4-chloro-2-hydroxy-3-(piperidin-3-ylsulfonyl)phenyl)-3-(3-fluoro-2-methylphenyl)urea

Danirixin structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$54.00Login to see priceInquiryInquiry
10mg98%$80.00Login to see priceInquiryInquiry
25mg98%$136.00Login to see priceInquiryInquiry
50mg98%$229.00Login to see priceInquiryInquiry
100mg98%$389.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDanirixin
IUPAC Name(S)-1-(4-chloro-2-hydroxy-3-(piperidin-3-ylsulfonyl)phenyl)-3-(3-fluoro-2-methylphenyl)urea
MDL No.MFCD27987922
Molecular FormulaC19H21ClFN3O4S
Molecular Weight441.91
SMILESO=C(NC1=CC=C(Cl)C(S([C@H]2CCCNC2)(=O)=O)=C1O)NC3=C(C)C(F)=CC=C3
InChI KeyNGYNBSHYFOFVLS-LBPRGKRZSA-N
SynonymAKOS030527036 | SCHEMBL1198688 | GTPL8500 | HY-B1568 | UNII-R318PGH5VP | SPBio_002358 | MLS003899212 | EX-A1178 | GSK1325756B | GSK-1325756B | HY-19768 | AC-36168 | KBio1_000455 | GSK 1325756 | GSK1325756 | GSK-1325756 | DANIRIXIN [INN] | D10387 | Danirix
CAS No.954126-98-8
PubChem CID24780598

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACFKWI421 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFKWI421 route product structure diagram
    ACFKWI421954126-98-8
Inquiry

2. ACFKWI421 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFKWI421 route product structure diagram
    ACFKWI421954126-98-8
Inquiry

Comments (0)